ArticleCancers2024

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy.

Julian Kött et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.